From Wikipedia, the free encyclopedia
Jump to navigation Jump to search
Methamnetamine structure.png
Legal status
Legal status
PubChem CID
Chemical and physical data
Molar mass199.297 g·mol−1
3D model (JSmol)

Methamnetamine (also known as methylnaphetamine, MNA, MNT and PAL-1046) is a triple monoamine releasing agent and N-methyl analog of the non-neurotoxic experimental drug naphthylaminopropane and the naphthalene analog of methamphetamine.[1] It has been sold online as a designer drug.[2][3]

It acts as a releasing agent of serotonin, norepinephrine, and dopamine, with EC50 values of 13 nM, 34 nM, and 10 nM, respectively.[1]

Legal status[edit]

Methamnetamine is illegal in Japan.[4]

See also[edit]


  1. ^ a b Rothman RB, Partilla JS, Baumann MH, Lightfoot-Siordia C, Blough BE (April 2012). "Studies of the biogenic amine transporters. 14. Identification of low-efficacy "partial" substrates for the biogenic amine transporters". The Journal of Pharmacology and Experimental Therapeutics. 341 (1): 251–62. doi:10.1124/jpet.111.188946. PMC 3364510. PMID 22271821.
  2. ^ "Methamnetamine". WEDINOS.
  3. ^ "Methamnetamine". New Synthetic Drugs Database.
  4. ^ "指定薬物名称・構造式一覧(平成27年9月16日現在)" (PDF) (in Japanese). 厚生労働省. 16 September 2015. Retrieved 8 October 2015.